bpc 157 tb 500 peptide

• BPC-157 (Body Protection Compound): Primarily focuses on angiogenesis (creating new blood vessels) and increasing the expression of growth hormone receptors in fibroblasts. It is most effective for “white tissue” with poor blood supply, such as tendons and ligaments bpc 157 tb 500 peptide[1, 2].
• TB-500 (Thymosin Beta-4 fragment): Acts systemically by regulating actin, a protein essential for cell structure and movement. It promotes the migration of repair cells to the injury site and significantly reduces systemic inflammation and the formation of restrictive scar tissue [3, 4].

• Acute & Chronic Injuries: Studied for treating rotator cuff tears, Achilles tendonitis, ACL/MCL sprains, and muscle tears [2, 5].
  • • • Post-Surgical Recovery: Used in research to investigate faster rehabilitation times and reduced inflammation following orthopedic surgery [1].
      • Gastrointestinal Repair: BPC-157 is uniquely studied for its ability to heal the gut lining in cases of “leaky gut” or inflammatory bowel disease (IBD) [2].
  Administration and Handling
  • • • The Blend: Often sold as a 20mg blend (10mg of each) in a single vial [1].
      • Reconstitution: Requires Bacteriostatic Water for injection [1, 3].
      • Storage: Must be stored in a refrigerator (2°C–8°C) once mixed. Peptides are fragile; vials should be swirled gently rather than shaken [1, 4].
  Safety and Regulatory Status (2026)
  • • FDA Status: Neither BPC-157 nor TB-500 is FDA-approved for human use. In late 2023/2024, the FDA placed BPC-157 on the “Category 2” list, prohibiting compounding pharmacies from producing it for humans due to limited safety data [5].
    • WADA Status: Strictly prohibited at all times (in and out of competition) by the World Anti-Doping Agency (WADA) [1, 3].
    • Side Effects: Generally reported as well-tolerated in animal models, but human risks may include nausea, lightheadedness, and injection site irritation [5].